You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mineralocorticoid

Showing 26 - 50 of 362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitreomacular Traction, Subretinal Edema Trial in Norfolk (Eplerenone)

Terminated
  • Vitreomacular Traction
  • Subretinal Edema
  • Norfolk, Virginia
    Wagner Macula & Retina Center
Jan 6, 2021

STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • Left Ventricular Systolic Dysfunction
  • Dapagliflozin 10Mg Tab
  • Placebo
  • (no location specified)
Sep 6, 2021

Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Recruiting
  • Chronic Renal Failure
  • Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
  • Dapagliflozin 10mg Tab
  • +5 more
  • Marseille, France
  • +1 more
May 23, 2023

Hypotension, Heart Failure Trial in Taipei (Dapagliflozin, Sacubitril-Valsartan, Beta blocker)

Completed
  • Hypotension
  • Heart Failure
  • Taipei, Taiwan
    Cheng Hsin General Hospital
Jul 27, 2021

Partial Mineralocorticoid Deficiency Trial in Paris (Oral Fludrocortisone (enteral), Placebo Oral Tablet)

Completed
  • Partial Mineralocorticoid Deficiency
  • Oral Fludrocortisone (enteral)
  • Placebo Oral Tablet
  • Paris, France
    Hôpital Robert Debré
Feb 15, 2021

Glucose Metabolism in Aldosterone-Producing Adenomas

Completed
  • Primary Aldosteronism
  • Adrenalectomy
  • mineralocorticoid receptor antagonist
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Apr 28, 2021

Major Depression Trial in Berlin (Placebo, Fludrocortisone, D-Cycloserine)

Completed
  • Major Depression
  • Placebo
  • +2 more
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Jun 19, 2020

Ovarian Hyperstimulation Syndrome Trial in Cairo (Fludrocortisone 0.1 Milligrams (mg), Bromocriptine)

Completed
  • Ovarian Hyperstimulation Syndrome
  • Cairo, Maadi, Egypt
    Ganin Fertility Center
Apr 16, 2020

Heart Failure With Reduced Ejection Fraction Trial in Los Angeles (Email Nudge)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Email Nudge
  • Los Angeles, California
    University of California, Los Angeles
Apr 7, 2023

Heart Failure Trial in Worldwide (OPTIMIZER, Optimal medical therapy)

Terminated
  • Heart Failure
  • OPTIMIZER
  • Optimal medical therapy
  • Graz, Austria
  • +7 more
Sep 1, 2020

Type 1 Diabetes Trial in Charlottesville (Exercise, Spironolactone)

Completed
  • Type 1 Diabetes
  • Charlottesville, Virginia
    University of Virginia
Dec 17, 2019

Healthy Trial in Ann Arbor (High-sodium diet 300 mmol sodium/day, Low-sodium diet 10 mmol sodium/day)

Completed
  • Healthy
  • High-sodium diet 300 mmol sodium/day
  • Low-sodium diet 10 mmol sodium/day
  • Ann Arbor, Michigan
    University of Michigan
Feb 4, 2022

Salt Wasting, Hydro-sodium Balance and Fludrocortisone

Completed
  • Congenital Adrenal Hyperplasia (CAH)
    • Paris, France
      Hôpital Robert Debré
    Sep 15, 2022

    ADPKD Trial in Aurora (Spironolactone, Sugar pill)

    Completed
    Has Results
    • ADPKD
    • Aurora, Colorado
      UColorado
    Aug 1, 2019

    Hearing Loss, Sensorineural Trial in Portland (Fludrocortisone)

    Terminated
    • Hearing Loss, Sensorineural
    • Portland, Oregon
      Oregon Health & Science University
    Oct 15, 2019

    Heart Failure Trial in New York (Spironolactone 100mg, Spironolactone 25mg)

    Completed
    Has Results
    • Heart Failure
    • Spironolactone 100mg
    • Spironolactone 25mg
    • New York, New York
      Columbia University Medical Center
    Jul 24, 2019

    HF - Heart Failure, Diabetes Trial in Chicago (Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg)

    Withdrawn
    • HF - Heart Failure
    • Diabetes Mellitus
    • Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg
    • Chicago, Illinois
      Northwestern University
    May 4, 2022

    Acute Heart Failure Trial

    Not yet recruiting
    • Acute Heart Failure
      • (no location specified)
      May 9, 2023

      Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

      Not yet recruiting
      • Heart Failure
      • +3 more
      • (no location specified)
      Oct 17, 2023

      Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated

      Completed
      • Bioequivalence
      • Healthy Subjects
      • Efez 50 mg eplerenone film-coated tablets
      • INSPRA® 50 mg eplerenone film-coated tablets
      • Amman, Jordan
        ACDIMA Center for Bioequivalence and Pharmaceutical Studies
      Dec 15, 2022

      MRA and ARB Treatment in Screening of Primary Aldosteronism

      Completed
      • Primary Aldosteronism Due to Aldosterone Producing Adenoma
      • canrenone 50-100 mg orally once a day
      • olmesartan 10-20 mg orally once a day
      • Padova, Italy
        Department of Medicine - DIMED, University of Padova, Italy
      Dec 2, 2019

      Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)

      Completed
      • Primary Hyperparathyroidism
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Nov 26, 2021

      SGLT-2 Inhibitors in the Treatment of Ascites

      Recruiting
      • Ascites Hepatic
      • +2 more
      • SGLT2 inhibitor
      • Palermo, Italy
      • +1 more
      Aug 11, 2023

      Alcohol Use Disorder Trial in Baltimore (Spironolactone, Placebo)

      Not yet recruiting
      • Alcohol Use Disorder
      • Baltimore, Maryland
        National Institute on Drug Abuse
      Apr 10, 2023

      Heart Failure Trial in Stanford (Routine Health Status Assessment)

      Enrolling by invitation
      • Heart Failure
      • Routine Health Status Assessment
      • Stanford, California
        Stanford Hospital & Clinics
      Sep 29, 2022